CytomX Therapeutics, Inc. Balance Sheet

Balance Sheet Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 73.06M197.22M199.13M397.64M457.11M341.28M358.66M339.41M260.89M201.79M120.53M
Current Assets
Cash & Equivalents 8.70M64.40M59.82M104.64M177.55M247.58M188.43M191.86M205.53M193.65M17.17M38.05M
Short-term Investments 126.89M77.29M196.56M188.55M107.72M124.26M99.70M157.34M62.57M
Cash & Current Investments 8.70M64.40M186.71M181.94M374.11M436.13M296.14M316.12M305.23M193.65M174.51M100.62M
Receivables - Net 1.88M0.37M2.16M10.14M0.10M0.01M0.80M0.79M35.99M3.43M3.10M
Receivables - Other 0.37M0.15M10.10M0.10M0.01M0.80M0.80M35.00M2.20M1.10M
Receivables 1.88M0.74M2.31M20.24M0.19M0.03M1.60M1.59M70.99M5.63M4.20M
Prepaid Assets 0.48M2.30M3.90M4.35M9.25M7.18M7.10M4.29M7.47M5.00M3.58M
Current Assets 66.85M189.75M188.15M388.60M445.48M303.33M324.01M310.30M237.10M182.94M107.31M
Non-Current Assets
Construction in Progress 0.02M0.79M0.24M0.25M0.31M0.70M0.37M
Property, Plant & Equipment (Net) 3.02M3.48M4.39M4.22M6.93M7.37M6.95M5.96M5.07M3.96M2.47M
Goodwill 0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M0.95M
Intangibles 1.75M1.75M1.75M1.60M1.46M1.31M1.17M1.02M0.88M0.73M0.58M
Goodwill & Intangibles 2.70M2.70M2.70M2.55M2.41M2.26M2.12M1.97M1.82M1.68M1.53M
Other Non-Current Assets 0.49M0.92M0.92M0.92M0.92M0.92M2.17M0.92M0.92M0.92M1.03M
Non-Current Assets 6.21M7.46M10.98M9.04M11.63M37.95M34.65M29.11M23.79M18.86M13.23M
Liabilities
Current Liabilities
Accounts Payables 1.92M4.70M6.60M4.21M5.13M4.16M3.00M2.82M2.81M1.46M1.09M
Payables 1.92M4.70M6.60M4.21M5.13M4.16M3.00M2.82M2.81M1.46M1.09M
Accumulated Expenses 1.70M4.91M8.82M16.38M26.72M30.05M23.06M34.24M24.45M17.60M12.34M
Other Accumulated Expenses 0.14M0.21M0.35M0.27M0.79M0.45M0.59M0.71M0.26M0.31M0.49M
Short term Debt 1.42M
Current Leases 2.81M3.62M4.08M4.59M5.14M
Current Taxes 0.00M13.34M
Current Deferred Revenue 6.13M60.90M20.35M305.26M277.98M255.88M318.71M284.76M301.33M212.31M94.06M
Total Current Liabilities 11.16M15.74M35.77M61.15M97.91M85.59M68.11M77.87M152.61M155.91M85.77M
Non-Current Liabilities
Non-Current Debt 1.57M
Non-Current Deffered Revenue 60.83M54.70M83.80M264.70M225.27M178.86M276.65M243.94M180.06M80.05M26.86M
Preferred Stock Liabilities 76.71M
Non-Current Deferred Tax Liability 0.50M0.51M0.51M
Operating Leases 24.87M21.68M18.06M13.97M9.38M4.24M
Other Non-Current Liabilities 0.25M0.20M0.57M1.90M3.05M0.85M3.89M4.12M
Total Non-Current Liabilities 74.64M70.95M120.08M325.85M323.18M289.32M245.35M116.87M
Liabilities
Total Liabilities 44.28M74.89M71.15M120.65M327.75M326.23M290.17M366.44M339.87M346.64M249.24M120.99M
Shareholder's Equity
Total Debt 2.99M
Common Equity -44.28M-78.54M126.07M78.48M69.90M130.88M25.47M-7.77M-0.46M-85.75M-47.45M-0.46M
Shareholder's Equity -44.28M-78.54M126.07M78.48M69.90M130.88M25.47M-7.77M-0.46M-85.75M-47.45M-0.46M
Liabilities and Shareholders Equity 73.06M197.22M199.13M397.64M457.11M341.28M358.66M339.41M260.89M201.79M120.53M
Retained Earnings -78.14M-117.47M-176.37M-219.47M-314.98M-442.87M-507.69M-623.56M-722.88M-723.45M-691.58M
Preferred Shares 76.24M
Treasury Shares 0.87M1.21M1.40M1.85M